Osteoarthritis
Conference Coverage
Methotrexate significantly reduced knee OA pain
TORONTO – “I think there is a signal in this study.” – Dr. Philip G. Conaghan
Conference Coverage
Scandinavian studies shed light on OA inheritance
TORONTO – OA risk appears to be passed mother to daughter, studies show.
Conference Coverage
Tanezumab acts fast for OA pain relief
TORONTO – The nerve growth factor inhibitor separated from placebo in the first 3-5 days in a phase 3 randomized, controlled trial.
Conference Coverage
Warfarin boosts OA risk in Rotterdam Study
TORONTO – Warfarin therapy was linked with more than doubled risks of knee and hip osteoarthritis in the Rotterdam Study.
Conference Coverage
Upcoming OA management guidelines reveal dearth of effective therapies
TORONTO –
Conference Coverage
Patients rate burden of OA equal to RA
TORONTO – “The severity of disease burden in OA to the patient appears to be underrated by the medical community, general public, and even...
Conference Coverage
Bundled payment for OA surgery linked to more emergency department visits
TORONTO – Ontario experience with bundling payment for surgery documents a sharp uptick in postdischarge unplanned emergency department visits.
Conference Coverage
PT beats steroid injections for knee OA
TORONTO – Eight sessions of physical therapy provided superior WOMAC score improvement from 4 weeks to 1 year.
Conference Coverage
High-intensity statins may cut risk of joint replacement
TORONTO – Huge propensity-matched study spotlights a potential statin side benefit: less need for joint replacement...
News from the FDA/CDC
Arthritis joint pain, inactivity vary greatly across U.S.
The Southeast has the highest rates of adults with severe joint pain and physical inactivity, the CDC reports.
From the Journals
Four biomarkers could distinguish psoriatic arthritis from osteoarthritis
The four-biomarker panel could offer a way to make earlier diagnoses and avoid inappropriate treatment.